Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NuPlant has commercialized its SmartClone™ automated tissue culture system, achieving significant improvements in plantlet quality, labor efficiency (up to 5-fold reduction in labor costs), and cost reductions (up to 90%) compared to conventional tissue culture methods. The system has demonstrated superior plantlet quality, faster crop turnaround, and higher survivability in crops such as grapes, potatoes, blueberries, and ornamental species. NuPlant currently has 11 SmartClone™ robots operating internationally, including deployments in North America, Europe, China, and Australia, with applications in horticulture, forestry, cannabis, and nut tree propagation[2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuPlant.